BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioCapital

  NIKA Awarded $25M IDIQ Contract for OCONUS Medical Facilities Support Services (MFSS II) by the U.S. Army Corps of Engineers

  NIKA, a global provider of facility life cycle solutions announced that it has been awarded its first full and open contract by the U.S. Army Corps of Engineers (USACE

  August 6, 2019

   · 

  2 min read
• BioCapital

  Constellation Accepting Applications for 2019 Energy to Educate Grant Program

  Constellation, an Exelon company, is accepting applications for its 2019 E2 Energy to Educate grant program, which provides funding for student research projects focusing on energy innovation.

  August 6, 2019

   · 

  3 min read
• Business

  Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast

  Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its second quarter 2019 financial results before the market opens on Thursday, August 8, 2019.

  August 6, 2019

   · 

  1 min read
• Business

  25 Year Follow up with Geistlich Bio-Oss Collagen®

  Drawing from his company’s rich history in bone and collagen processing, Dr. Peter Geistlich formulated a propriety technique in the 1980’s to remove organic components from bone without altering the natural microstructure and composition.

  August 6, 2019

   · 

  2 min read
• BioCapital

  Following Tragic Shootings in El Paso and Dayton, New Report Recommends Wide Range of Actionable Solutions to Reduce Mass Violence

  Behavioral Health-based Report Recommends Communitywide Response to Mass Violence

  August 6, 2019

   · 

  5 min read
• Policy

  FDA statement on court ruling related to compounded bulk drug substances and the agency’s ongoing efforts to implement its compounding authorities

  Acting FDA Commissioner Ned Sharpless, M.D. - Acting Commissioner of Food and Drugs - Food and Drug Administration Director of the FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D.

  August 6, 2019

   · 

  4 min read
• Business

  Global Genes® Appoints New CEO, Kimberly Haugstad

  On September 1, 2019, Kimberly Haugstad will join Global Genes® as its chief executive officer

  August 6, 2019

   · 

  2 min read
• Genetown

  Gamida Cell Reports Second Quarter 2019 Financial Results and Provides Company Update

  Gamida Cell Ltd., a leading cellular and immune therapeutics company, reported financial results for the quarter ended June 30, 2019.

  August 6, 2019

   · 

  17 min read
• BioMidwest

  Vireo Health to Present at the 39th Annual Canaccord Genuity Growth Conference

  Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced its participation at the 39th Annual Canaccord Genuity Growth Conference in Boston on May 8, 2019.

  August 6, 2019

   · 

  2 min read
• BioCapital

  HemoShear Therapeutics to Present at Wedbush PacGrow Healthcare Conference

  HemoShear Therapeutics, LLC, a privately held biotechnology company focused on discovering and developing drugs for metabolic disorders, today announced that Jim Powers, Chairman and CEO, will present at the 2019 Wedbush PacGrow Healthcare Conference

  August 6, 2019

   · 

  1 min read